首页 | 本学科首页   官方微博 | 高级检索  
     


Human drug metabolising cytochrome P450 enzymes: properties and polymorphisms
Authors:Magnus?Ingelman-Sundberg  author-information"  >  author-information__contact u-icon-before"  >  mailto:maging@ki.se"   title="  maging@ki.se"   itemprop="  email"   data-track="  click"   data-track-action="  Email author"   data-track-label="  "  >Email author
Affiliation:(1) Division of Molecular Toxicology, Institute of Environmental Medicine, Karolinska Institutet, Nobels väg 13, 171 77 Stockholm, Sweden
Abstract:The cytochrome P450s are responsible for about 75% of phase I dependent drug metabolism and for the metabolism of a huge amount of dietary constituents and endogenous chemicals. The human has 59 active genes, and 6 of those encode important drug metabolising enzymes. About 40% of cytochrome P450 dependent drug metabolism is catalysed by polymorphic enzymes and such drug P450 interactions are frequently seen in adverse drug reaction reports. In this contribution an update of human cytochrome P450 enzymology and pharmacogenetics is given with particular emphasis on CYP1B1, CYP2B6, CYP2E1 and CYP3As.
Keywords:Poor metabolizers  Adverse drug reactions  Genetic polymorphism  Haplotypes  Cancer drugs  Ultrarapid metabolizers
本文献已被 PubMed SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号